On ECHEMI
Home > Drugs > Pulmonary edema
Pulmonary edema
Pulmonary edema refers to the imbalance of the production and reflux of tissue fluid in the lungs caused by some reasons, so that a large amount of tissue fluid cannot be absorbed by the pulmonary lymphatics and pulmonary venous system in a very short time, and it infiltrates from the pulmonary capillaries and accumulates in the alveoli, pulmonary interstitium and small bronchi, thus causing serious obstruction of pulmonary ventilation and gas exchange function. Clinically, it manifests as extreme dyspnea, sitting breathing, cyanosis, sweating, paroxysmal cough with a large amount of white or pink foamy sputum, symmetrical moist rales in both lungs, and butterfly-shaped flake-like blurred shadows in both lungs can be seen in the chest X-ray. Shock or even death may occur in the late stage. Arterial blood gas analysis may show low O2, low CO2 partial pressure, severe lack of O2, CO2 retention and mixed acidosis in the early stage, which is one of the clinical critical diseases.
  • Site of disease:

    lung
  • Infectious :

    Not contagious
  • Frequent population:

    All groups
  • Related symptoms:

    Orthopnea dyspnea wet rales imbalance of pulmonary ventilation and blood flow mixed acid-base disorder
  • Concurrent disease:

Related Drugs
Isosorbide dinitrate spray
Indication: It is used to prevent and treat various types of coronary heart disease and angina pectoris, especially for severe angina pectoris. When there are factors that induce angina pectoris such as mental stress, overwork, or the presence of premonitory symptoms, using this product in advance can prevent angina pectoris attacks.
Aminophylline Tablets
Indication: It is suitable for relieving wheezing symptoms of bronchial asthma, asthmatic bronchitis, obstructive pulmonary emphysema, etc.; it can also be used for asthma caused by cardiogenic pulmonary edema.
Manufacturer:

Shanghai Yurui BIOTECHNOLOGY (Anyang) Pharmaceutical Co., Ltd.

Theophylline sustained-release tablets
Indication: It is suitable for relieving wheezing symptoms of bronchial asthma, asthmatic bronchitis, obstructive pulmonary emphysema, etc.; it can also be used to relieve wheezing during heart failure.
Manufacturer:

Guangzhou Baiyunshan Guanghua Pharmaceutical Co., Ltd.

Theophylline sustained-release tablets
Indication: It is suitable for relieving wheezing symptoms of bronchial asthma, asthmatic bronchitis, obstructive pulmonary emphysema, etc.; it can also be used for asthma caused by cardiogenic pulmonary edema.
Manufacturer:

Shandong LINUO Pharmaceutical Company Limited

Theophylline sustained-release tablets
Indication: It is mainly used to treat bronchial asthma, cardiac asthma, emphysema, chronic bronchitis, etc.; it can also be used for diuresis and swelling reduction of cardiogenic and renal edema.
Manufacturer:

Jilin Yatai Pharmaceutical Co., Ltd.

Theophylline sustained-release tablets
Indication: It is suitable for relieving wheezing symptoms such as bronchial asthma, asthmatic bronchitis, obstructive pulmonary emphysema, etc.
Manufacturer:

China Resources Zizhu Pharmaceutical Co., Ltd.

Theophylline sustained-release tablets
Indication: It is suitable for relieving wheezing symptoms of bronchial asthma, asthmatic bronchitis, obstructive pulmonary emphysema, etc.; it can also be used for asthma caused by cardiogenic pulmonary edema.
Manufacturer:

Shandong Xinhua Pharmaceutical Company Limited

Diphylline Injection
Indication: It is suitable for bronchial asthma, asthmatic bronchitis, obstructive pulmonary emphysema, etc. to relieve wheezing symptoms. It is also used for asthma caused by cardiogenic pulmonary edema.
Manufacturer:

Shiyao YINHU Pharmaceutical Co., Ltd.

Hemofiltration replacement fluid
Indication: 1. Hemofiltration can be used to treat chronic renal failure, patients who cannot control volume balance satisfactorily with conventional hemodialysis, patients with refractory hypertension and heart failure, and patients who are prone to hypotension and imbalance syndrome with conventional hemodialysis. 2. Treatment of acute renal failure, especially for patients with severe hypervolemia, acute pulmonary edema and unstable cardiovascular function with hypotension.
Manufacturer:

Huaren Pharmaceutical Co., Ltd.

Hemofiltration replacement fluid
Indication: 1. Hemofiltration can be used to treat chronic renal failure, patients who cannot control volume balance satisfactorily with conventional hemodialysis, patients with refractory hypertension and heart failure, and patients who are prone to hypotension and imbalance syndrome with conventional hemodialysis. 2. Treatment of acute renal failure, especially for patients with severe hypervolemia, acute pulmonary edema and unstable cardiovascular function with hypotension.
Manufacturer:

Shanghai Changzheng Fumin Jinshan Pharmaceutical Co., Ltd.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.